Peanut allergy represents a growing pediatric healthcare challenge worldwide, including in urban Indian clinical settings. Fortunately, recent evidence highlights that peanut allergy prevention is highly achievable through early dietary interventions. Specifically, introducing peanut protein to infants can reduce allergy risk by approximately 80%. Conversely, delaying this introduction diminishes the protective efficacy. Therefore, pediatricians must adopt proactive dietary recommendations to curb this rising trend.
Guidelines for Peanut Allergy Prevention
Clinicians must carefully tailor the dosage based on the infant’s risk profile. For low-risk infants, parents should introduce approximately 2 grams of peanut protein weekly. However, high-risk infants with severe eczema or egg allergy require 4 to 6 grams of peanut protein weekly. Additionally, the Indian Academy of Paediatrics now recommends introducing complementary allergenic foods between six and nine months of age. Population-level implementation achieves a far greater reduction in overall disease burden than targeting high-risk infants alone. Nevertheless, healthcare disparities still limit access to care for certain ethnic and socio-economic groups.
Immunotherapy and Clinical Remission
When prevention is no longer an option, peanut immunotherapy offers a viable treatment path. Specifically, initiating immunotherapy in younger children between 1 and 3 years of age yields superior efficacy. Consequently, these young toddlers achieve higher rates of clinical remission compared to older children. Indeed, untreated peanut allergy usually follows a trajectory of increasing clinical reactivity over time. Furthermore, the patient’s peanut-specific IgE levels continue to rise. This progressive worsening underscores the critical importance of early intervention. Therefore, clinicians should act promptly during this narrow developmental window to modify the disease course.
Frequently Asked Questions
Q1: What is the recommended weekly dose of peanut protein for allergy prevention?
Low-risk infants should consume approximately 2 grams of peanut protein weekly. Meanwhile, high-risk infants require 4 to 6 grams of peanut protein weekly to achieve protective benefits.
Q2: Why is early pediatric peanut immunotherapy highly recommended?
Initiating immunotherapy in younger children aged 1 to 3 years leads to superior clinical efficacy. Moreover, younger patients achieve much higher rates of clinical remission compared to older children.
Q3: When should parents introduce peanuts to infants according to Indian guidelines?
The Indian Academy of Paediatrics recommends introducing allergenic complementary foods between six and nine months of age. Consequently, this early exposure successfully lowers the risk of developing severe food allergies.
References
- Du Toit G et al. Prevention and Treatment of Peanut Allergy. N Engl J Med. 2026 Jun 25. doi: 10.1056/NEJMcp2314424. PMID: 42341303.
- Nagarajan S et al. Indian Academy of Paediatrics (IAP) Expert Consensus Guidelines on Food Allergy. Indian Pediatr. 2026.
- Hill D et al. Real-world impact of early allergen introduction on peanut allergy prevalence. Pediatrics. 2025 Oct.